DCAF6 and myasthenia gravis: Considering that all MG patients with seropositive for anti‐NRIP autoantibody also had concomitant anti‐AChR antibody, we hypothesized that anti‐AChR autoantibody first binds AChR with activation of the complement cascade and membrane destruction, leading to the exposure of NRIP.